Arthritis News and Research

Latest Arthritis News and Research

Clinical trial to investigate effectiveness of antimalarial drugs for COVID-19 treatment

Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital.

9 Apr 2020

COVID-19 crisis threatens beleaguered assisted living industry

David Aguirre jumped in his truck and drove toward the hospital in the predawn darkness the minute he got the news: His 91-year-old mom was being rushed from her Texas assisted living facility to the emergency room.

9 Apr 2020

Potential harms associated with some drugs used for treating COVID-19 patients

Chloroquine, hydroxychloroquine and azithromycin are being used to treat and prevent COVID-19 despite weak evidence for effectiveness, and physicians and patients should be aware of the drugs' potentially serious adverse events, states a review in CMAJ.

8 Apr 2020

Autoimmunity appears to be increasing in the U.S.

Autoimmunity, a condition in which the body's immune system reacts with components of its own cells, appears to be increasing in the United States, according to scientists at the National Institutes of Health and their collaborators.

8 Apr 2020

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

For 10 days last month, they lay in side-by-side isolation units in a Seattle-area hospital, tethered to oxygen and struggling to breathe as the coronavirus ravaged their lungs.

6 Apr 2020

‘Staying away from grandma’ isn’t an option in multigenerational homes

The Walker family never thought having an age range of 3 to 96 under the same roof would be risky.

6 Apr 2020

Who should be taking antimalarial drugs as treatment against COVID-19?

Researchers provide a guideline regarding who should be actually taking antimalarial drugs as prophylaxis to prevent getting COVID-19. They say health professionals who are being exposed to COVID-19 positive patients and those who test positive but are asymptomatic should be taking drugs such as Chloroquine and Hydroxychloroquine. They explain that these populations remain most in need, and because of limited supply, these individuals need to be prioritized.

2 Apr 2020

UIC participates in two clinical trials for COVID-19 treatments

The University of Illinois at Chicago is participating in two clinical trials for COVID-19 treatments.

2 Apr 2020

Researchers say that NSAIDs, JAK inhibitors and TNF blockers are safe to use in COVID-19

Amid the coronavirus disease (COVID-19) pandemic, many theories have emerged about the disease and the treatments that can in supportive care. A recent theory emerged that suggests non-steroidal anti-inflammatory drugs (NSAIDs) might exacerbate the symptoms of the novel coronavirus. Now, a new study shows that there is no evidence for or against the use of NSAIDS, particularly ibuprofen, for patients with COVID-19.

1 Apr 2020

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

The U.S. Food and Drug Administration (FDA) this week provided the necessary authorization for clinical trials of chloroquine and hydroxychloroquine for the treatment of the novel coronavirus. These two drugs have been claimed by President Donald Trump to be a potential treatment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes COVID-19 disease. To date, there has been no conclusive proof regarding the safety and efficacy of these drugs in COVID-19 cases, say officials.

31 Mar 2020

Total-body PET provides suitable images of antibodies up to 30 days after injection

Combining 89Zr-labeled antibodies with total-body positron emission tomography (PET) has extended the utility of novel total-body PET scanners, providing suitable images up to 30 days after the initial injection.

31 Mar 2020

Individuals taking glucocorticoids are at high risk if infected with COVID-19

Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according to a new editorial published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

31 Mar 2020

Arthritis News and Research

Latest Arthritis News and Research

Clinical trial to investigate effectiveness of antimalarial drugs for COVID-19 treatment

COVID-19 crisis threatens beleaguered assisted living industry

Potential harms associated with some drugs used for treating COVID-19 patients

Autoimmunity appears to be increasing in the U.S.

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

‘Staying away from grandma’ isn’t an option in multigenerational homes

Who should be taking antimalarial drugs as treatment against COVID-19?

UIC participates in two clinical trials for COVID-19 treatments

Researchers say that NSAIDs, JAK inhibitors and TNF blockers are safe to use in COVID-19

FDA to trial malaria drugs Chloroquine and Hydroxychloroquine for COVID-19

Total-body PET provides suitable images of antibodies up to 30 days after injection

Individuals taking glucocorticoids are at high risk if infected with COVID-19

NIH researchers identify a second gene that causes melorheostosis

New study helps identify drugs that are safe for treating COVID-19

Temple researchers reverse muscle fibrosis associated with overuse injury in animals

UC Davis launches two clinical trials to evaluate treatments for COVID-19

Removing a gene prevents Type 1 diabetes in mice by disguising beta cells

FDA approves immune-modulating therapy for treatment of multiple sclerosis

Deleting a gene prevents Type 1 diabetes in mice by disguising insulin-producing cells

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Arthritis News and Research

Latest Arthritis News and Research

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in